Brian Sherer

789 total citations
15 papers, 369 citations indexed

About

Brian Sherer is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Brian Sherer has authored 15 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Organic Chemistry. Recurrent topics in Brian Sherer's work include Chronic Lymphocytic Leukemia Research (5 papers), Cancer therapeutics and mechanisms (4 papers) and Biochemical and Molecular Research (4 papers). Brian Sherer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Cancer therapeutics and mechanisms (4 papers) and Biochemical and Molecular Research (4 papers). Brian Sherer collaborates with scholars based in United States, Italy and Switzerland. Brian Sherer's co-authors include Maria Uria-Nickelsen, Ann E. Eakin, Ruth Illingworth, Gregory S. Basarab, John I. Manchester, Pamela Hill, Sheila I. Hauck, P. Ann Boriack‐Sjodin, Theresa Johnson and Kenneth G. Hull and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.

In The Last Decade

Brian Sherer

14 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Sherer United States	10	235	134	72	71	53	15	369
Nagashayana Natesh India	6	369 1.6×	66 0.5×	66 0.9×	12 0.2×	32 0.6×	6	516
Michael Hale United States	13	329 1.4×	240 1.8×	14 0.2×	49 0.7×	17 0.3×	18	650
Delphine S. Fischer United Kingdom	9	198 0.8×	136 1.0×	25 0.3×	36 0.5×	5 0.1×	9	460
Yu‐Jen Yu Taiwan	8	444 1.9×	154 1.1×	95 1.3×	15 0.2×	12 0.2×	14	599
Aline Renata Pavan Brazil	10	202 0.9×	60 0.4×	7 0.1×	44 0.6×	16 0.3×	18	372
Ahmed S. Abdelsamie Egypt	12	160 0.7×	316 2.4×	34 0.5×	14 0.2×	8 0.2×	27	521
Antonella Pepe United States	13	264 1.1×	228 1.7×	13 0.2×	25 0.4×	11 0.2×	25	550
Madhusudhan Gowravaram United States	11	216 0.9×	169 1.3×	22 0.3×	40 0.6×	4 0.1×	11	363
Edmond Fleischer Germany	13	206 0.9×	51 0.4×	22 0.3×	11 0.2×	16 0.3×	24	351
Ahmed El-morsy Egypt	13	304 1.3×	578 4.3×	58 0.8×	15 0.2×	9 0.2×	29	753

Countries citing papers authored by Brian Sherer

Since Specialization

Citations

This map shows the geographic impact of Brian Sherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Sherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Sherer more than expected).

Fields of papers citing papers by Brian Sherer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Sherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Sherer. The network helps show where Brian Sherer may publish in the future.

Co-authorship network of co-authors of Brian Sherer

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Sherer. A scholar is included among the top collaborators of Brian Sherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Sherer. Brian Sherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Guler, Satenig, Alejandro Crespo, Richard D. Caldwell, et al.. (2023). Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression. ACS Medicinal Chemistry Letters. 14(5). 566–576. 14 indexed citations

Ali, Zahid, Richard D. Caldwell, A.S. Gardberg, et al.. (2021). Discovery of Covalent Bruton's Tyrosine Kinase Inhibitors with Decreased CYP2C8 Inhibitory Activity. ChemMedChem. 16(24). 3653–3662. 1 indexed citations

Vlach, Jaromir, Andrew T. Bender, Melinda Przetak, et al.. (2020). Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity. Journal of Pharmacology and Experimental Therapeutics. 376(3). 397–409. 50 indexed citations

Sherer, Brian, Andrew T. Bender, Albertina Pereira, et al.. (2020). O37 M5049, a novel potent and selective inhibitor of toll-like receptors 7 and 8 (TLR 7/8). Oral Presentations. A28.2–A28. 4 indexed citations

Xiao, Yufang, Srinivasa Karra, Andreas Goutopoulos, et al.. (2019). Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 29(13). 1660–1664. 9 indexed citations

Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit. Bioorganic & Medicinal Chemistry Letters. 28(17). 2939–2944. 19 indexed citations

Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(20). 3307–3311. 4 indexed citations

Caldwell, Richard D., Lesley Liu‐Bujalski, Igor Mochalkin, et al.. (2018). Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk. Bioorganic & Medicinal Chemistry Letters. 28(21). 3419–3424. 15 indexed citations

Caldwell, Richard D., Lesley Liu‐Bujalski, Andreas Goutopoulos, et al.. (2018). Discovery of Affinity‐Based Probes for Btk Occupancy Assays. ChemMedChem. 14(2). 217–223. 4 indexed citations

10.

Basarab, Gregory S., Pamela Hill, C. Edwin Garner, et al.. (2014). Optimization of Pyrrolamide Topoisomerase II Inhibitors Toward Identification of an Antibacterial Clinical Candidate (AZD5099). Journal of Medicinal Chemistry. 57(14). 6060–6082. 60 indexed citations

11.

Basarab, Gregory S., John I. Manchester, P. Ann Boriack‐Sjodin, et al.. (2013). Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents. Journal of Medicinal Chemistry. 56(21). 8712–8735. 69 indexed citations

12.

Uria-Nickelsen, Maria, et al.. (2012). Novel DNA gyrase inhibitors: Microbiological characterisation of pyrrolamides. International Journal of Antimicrobial Agents. 41(1). 28–35. 15 indexed citations

13.

Sherer, Brian, Kenneth G. Hull, Gregory S. Basarab, et al.. (2011). Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy. Bioorganic & Medicinal Chemistry Letters. 21(24). 7416–7420. 94 indexed citations

14.

DeOrazio, Russell J., et al.. (2011). A Simple Strategy for the Preparation of 6-Substituted 3H-Benzoxazol-2-ones and 3H-Benzothiazol-2-ones. Synthetic Communications. 41(23). 3551–3555.

15.

Hayes, Michael P., et al.. (2001). Regioselective synthesis of 13C1-labeled 2-deoxyribonolactones. Tetrahedron. 57(8). 1515–1524. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact